ARCHIVES

CCI Gets Qualified Approval To Continue

This article is from The Cancer Letter archive.

Vol. 06 No. 03 | January 18, 1980

Download PDF Visit The Full Archive

Related Articles

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

June 30, 2006

Funding Opportunities

February 28, 2003

In Breif: FDA Issues Uterine Cancer-Tamoxifin Warning; Fisher Declined Invitation To Speak At AACR

April 15, 1994

Age-adjusted cancer incidence and mortality down slightly, annual report finds.

June 4, 2004

Stand Up To Cancer Launches Immunology “Dream Team”

December 14, 2012

NCI May Ask Grantees To Assume Additional Services, Broder Says

November 11, 1994